Susquehanna International Group, LLP Immunity Bio, Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$3.32 - $6.7 $826,348 - $1.67 Million	-248,900 Reduced 39.14%	387,100 $1.44 Million
Q2 2024 Aug 15, 2024	BUY	$4.82 - $9.15 $602,982 - $1.14 Million	125,100 Added 24.49%	636,000 $4.02 Million
Q1 2024 May 07, 2024	BUY	$3.23 - $6.17 $1.42 Million - $2.71 Million	439,100 Added 611.56%	510,900 $2.74 Million
Q4 2023 Feb 14, 2024	SELL	$1.25 - $5.21 $413,500 - $1.72 Million	-330,800 Reduced 82.17%	71,800 $360,000
Q3 2023 Nov 14, 2023	BUY	$1.29 - $3.1 $106,038 - $254,820	82,200 Added 25.66%	402,600 $680,000
Q2 2023 Aug 11, 2023	BUY	$1.53 - $6.41 $193,239 - $809,583	126,300 Added 65.07%	320,400 $890,000
Q1 2023 May 16, 2023	SELL	$1.35 - $4.78 $171,855 - $608,494	-127,300 Reduced 39.61%	194,100 $353,000
Q4 2022 Feb 14, 2023	SELL	$4.35 - $6.77 $47,414 - $73,793	-10,900 Reduced 3.28%	321,400 $1.63 Million
Q3 2022 Nov 14, 2022	SELL	$3.65 - $6.43 $99,645 - $175,539	-27,300 Reduced 7.59%	332,300 $1.65 Million

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.